Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dehaier Medical Systems receives CFDA approval for Morpheus Ox Sleep Diagnostic Software

Thursday, 5 Jun 2014 09:00am EDT 

Dehaier Medical Systems Ltd:Receives approval from China Food and Drug Administration (CFDA) for its Morpheus Ox software. 

Latest Developments for Dehaier Medical Systems Ltd

Company Quote

0.14 +2.64%
21 Aug 2014